[HTML][HTML] Understanding factors that shape gender attitudes in early adolescence globally: A mixed-methods systematic review

A Kågesten, S Gibbs, RW Blum, C Moreau… - PloS one, 2016 - journals.plos.org
Background Early adolescence (ages 10–14) is a period of increased expectations for boys
and girls to adhere to socially constructed and often stereotypical norms that perpetuate …

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

S Masaldan, AI Bush, D Devos, AS Rolland… - Free Radical Biology …, 2019 - Elsevier
Perturbations in iron homeostasis and iron accumulation feature in several
neurodegenerative disorders including Alzheimer's disease (AD), Parkinson's disease (PD) …

Acetaminophen‐induced liver injury in obesity and nonalcoholic fatty liver disease

A Michaut, C Moreau, MA Robin… - Liver International, 2014 - Wiley Online Library
Although acetaminophen (APAP) is usually considered as a safe drug, this painkiller can
lead to acute liver failure after overdoses. Moreover, there is evidence that the maximum …

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double …

JF Howard, K Utsugisawa, M Benatar, H Murai… - The Lancet …, 2017 - thelancet.com
Background Complement is likely to have a role in refractory generalised myasthenia gravis,
but no approved therapies specifically target this system. Results from a phase 2 study …

[HTML][HTML] Trial of deferiprone in Parkinson's disease

D Devos, J Labreuche, O Rascol… - … England Journal of …, 2022 - Mass Medical Soc
Background Iron content is increased in the substantia nigra of persons with Parkinson's
disease and may contribute to the pathophysiology of the disorder. Early research suggests …

Targeting chelatable iron as a therapeutic modality in Parkinson's disease

D Devos, C Moreau, JC Devedjian, J Kluza… - Antioxidants & redox …, 2014 - liebertpub.com
Aims: The pathophysiological role of iron in Parkinson's disease (PD) was assessed by a
chelation strategy aimed at reducing oxidative damage associated with regional iron …

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

B Do Van, F Gouel, A Jonneaux, K Timmerman… - Neurobiology of …, 2016 - Elsevier
Parkinson's disease (PD) is a complex illness characterized by progressive dopaminergic
neuronal loss. Several mechanisms associated with the iron-induced death of dopaminergic …

STN-DBS frequency effects on freezing of gait in advanced Parkinson disease

C Moreau, L Defebvre, A Destée, S Bleuse, F Clement… - Neurology, 2008 - AAN Enterprises
Background: Severe gait disturbances and freezing episodes (frequently resistant to optimal
dopaminergic treatment) often appear in advanced Parkinson disease (PD). Even several …

Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours

N Bajos, K Wellings, C Laborde, C Moreau - Bmj, 2010 - bmj.com
Objectives To analyse the association between body mass index (BMI) and sexual activity,
sexual satisfaction, unintended pregnancies, and abortions in obese people and to discuss …

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double‐blind, randomized, placebo‐controlled study

D Devos, K Dujardin, I Poirot, C Moreau… - Movement …, 2008 - Wiley Online Library
Depression is one of the most common psychiatric disturbances in Parkinson's disease
(PD). Recent reviews have highlighted the lack of controlled trials and the ensuing difficulty …